Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT06241196 |
Other study ID # |
Implant_22 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
Phase 2
|
First received |
|
Last updated |
|
Start date |
July 1, 2022 |
Est. completion date |
April 1, 2024 |
Study information
Verified date |
January 2024 |
Source |
Tanta University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The aim of this study is to evaluate and compare the Vestibular Socket Therapy (VST)
technique using alloderm versus connective tissue graft both with xenogenic bone membrane in
immediate implants of anterior aesthetic zone.
Description:
Twenty surgical sites will be divided into two groups; each of which has 10 surgical sites.
Grouping will be done randomly sequentially numbered, opaque, sealed envelopes (SNOSE)
The groups will be treated as follow:
- Group I: Ten sites will be treated by immediate implant and VST with Alloderm +
allogenic bone membrane and xenograft.
- Group II: Ten sites will be treated by immediate implant and VST with connective tissue
graft + allogenic bone membrane and xenograft Each group will be subjected to intraoral
scanning at baseline, 6 months and 12 months. The changes in peri-implant mucosal level
will be assessed by superimposition of scanning files of different intervals to monitor
the changes in surface area calculated by software.
The changes in gingival phenotype could be assessed at 6 months and 12 months intervals by
superimposition of DICOM files on CBCT software Each group will be subjected to Cone Beam
Computed Tomography (CBCT) at baseline, 6 months and 12months to asses both thickness and
height of labial (facial) plate of bone and implant survival.